Junshi Biosciences(688180) 上海证券报·2025-04-11 20:34Core Viewpoint - The controlling shareholder and chairman of Shanghai Junshi Biosciences Co., Ltd., Mr. Xiong Jun, plans to increase his shareholding in the company by at least RMB 100 million over the next 12 months, starting from April 12, 2025, with a minimum of RMB 50 million allocated for A-shares [2][6][7]. Group 1: Shareholding Increase Plan - The increase in shareholding will be executed through the Shanghai Stock Exchange and the Hong Kong Stock Exchange, utilizing methods such as centralized bidding and block trading [12]. - Mr. Xiong currently holds 87,856,618 shares, representing 8.91% of the total share capital, and together with his concerted parties, they hold 183,983,186 shares, accounting for 18.67% of the total [4][18]. - The increase is motivated by Mr. Xiong's confidence in the company's future development and long-term investment value [6]. Group 2: Implementation Details - The planned increase does not specify a price range, allowing Mr. Xiong to decide based on market conditions [8]. - The implementation period for the shareholding increase is set for 12 months starting from April 12, 2025, with provisions for adjustments if the stock is suspended for more than 10 trading days [9][10]. - Funding for the increase will come from Mr. Xiong's own or self-raised funds [11]. Group 3: Shareholding Structure Changes - The announcement also details changes in the concerted action relationship among shareholders, with some parties no longer acting in concert, while new agreements have been established to maintain stability in control [19][22]. - Following the changes, the total shareholding of Mr. Xiong and his concerted parties remains at 183,983,186 shares, or 18.6654% of the total [22][27]. - The overall shareholding structure remains stable, ensuring that the controlling shareholders retain significant influence over company decisions [27][28].